Catalent vs Grand River Aseptic Manufacturing

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/catalent/grandriverasepticmfg

Category	Catalent	Grand River Aseptic Manufacturing
Listed site	cdmo	cdmo
Summary	Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity.	Sterile injectable CDMO specializing in fill-finish services for liquid and lyophilized vials, syringes, and cartridges, with Annex 1 compliant facilities and experience in biologics, small molecules, and vaccines.
Services	Cell Therapy Manufacturing Viral Vector Manufacturing AAV Manufacturing Oral Solid Dosage Manufacturing Inhalation & Nasal Dosage Manufacturing Formulation Development Process Development CMC Analytical Development Technology Transfer Sterile Fill-Finish & Aseptic Manufacturing Quality Control Testing Recombinant Protein Manufacturing Biologics Development & Manufacturing API Synthesis & Manufacturing Small Molecule Development & Manufacturing Monoclonal Antibody (mAb) Manufacturing Secondary Packaging & Labeling Stability Testing & Storage CMC Regulatory Submission Support Cell-Line Development Upstream Processing Downstream Processing Vial Filling Prefilled Syringe (PFS) Filling Topical & Semi-Solid Manufacturing Serialization & Track-and-Trace Cold-Chain Storage & Logistics Cartridge Filling Lyophilization (Freeze Drying) Lentiviral Vector Manufacturing	Sterile Fill-Finish & Aseptic Manufacturing Vial Filling Prefilled Syringe (PFS) Filling Cartridge Filling Lyophilization (Freeze Drying) Quality Control Testing Secondary Packaging & Labeling Serialization & Track-and-Trace Stability Testing & Storage CMC Analytical Development Technology Transfer CMC Regulatory Submission Support Controlled Substance Manufacturing Vaccine Manufacturing Monoclonal Antibody (mAb) Manufacturing Biologics Development & Manufacturing API Synthesis & Manufacturing Small Molecule Development & Manufacturing
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy AAV / Viral Vector Platform	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Vaccine
Indications	Data not yet provided.	Data not yet provided.
Locations	Headquarters, United States Asia Pacific, Asia Pacific Europe, Europe Latin America, Latin America North America, North America, United States China, China Japan, Japan North America, North America Global Network	Headquarters, Grand Rapids, Michigan, United States Headquarters
Certifications	GMP · Identifier: Nine GMP facilities	GMP · Identifier: Five GMP manufacturing facilities Annex 1 · Identifier: Three facilities designed and qualified with Annex 1 revisions GMP · Identifier: Five GMP manufacturing facilities; three Annex 1 compliant FDA · Identifier: GMP EMA · Identifier: Annex 1 GMP · Identifier: Five GMP manufacturing facilities (three Annex 1 compliant)
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.